Definitive Contract 75D30121C11016

Award Date 5/15/21
Potential Completion Date 5/14/23
Potential Value $1.1M
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to the Translational Genomics Research Institute (TGen), a non-profit research organization. The contract, valued at $109,504.00, is a Definitive Contract with a Firm Fixed Price under Broad Agency Announcement (BAA) 2017. The contract does not have a set-aside designation. Under this contract, TGen will provide a variety of genomic research services, including SARS-CoV-2...
This federal contract award, valued at $1,472,866.08, was issued by the Centers for Disease Control and Prevention (CDC) to the Translational Genomics Research Institute (TGen), a non-profit biomedical research organization. The contract provides bioinformatics support services, including genomic sequencing, analysis, and data services, to advance precision medicine research. TGen has previously conducted genomic research and analysis work for several federal agencies, such as the National...
This is a $145,000.00 firm fixed-price purchase order contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to the Translational Genomics Research Institute (TGen), a non-profit research organization. The contract is for RUN DATA SAMPLES services, with a completion date of September 29, 2024. TGen has previously performed genomic research services for federal agencies under both contracts and grants, including work related to SARS-CoV-2,...
This is a $77,025 purchase order contract awarded by the Indian Health Service, a civilian agency within the U.S. Department of Health and Human Services, to the Translational Genomics Research Institute (TGen) for COVID-19 (SARS-CoV-2) testing and translational genomics research. The contract does not have a set-aside designation. TGen is a non-profit biomedical research organization that specializes in genomic analysis and bioinformatics to advance precision medicine. Through this contract,...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services Indian Health Service to the Translational Genomics Research Institute (TGen), a non-profit research organization, for the provision of 1,000 SARS-CoV-2 nasopharyngeal PCR tests at $51.35 per test, for a total potential value of $205,400. The contract does not have a set-aside designation and was awarded in response to the COVID-19 National Interest Action. TGen has a history of providing genomic...
The Centers for Disease Control and Prevention (CDC) awarded a $716,320 purchase order to Theiagen Consulting LLC, doing business as Theiagen Genomics, for TERRA SUPPORT under its major program code for Communicable Disease. Theiagen Genomics will provide genomics support services from its location in Highlands Ranch, Colorado to the CDC in Pittsburgh, Pennsylvania over the one-year period beginning September 8, 2021 through August 14, 2022. The contract utilizes firm fixed pricing for the...
The Centers for Disease Control and Prevention (CDC) awarded a $39.9 million firm fixed price definitive contract to Aegis Sciences Corporation for COVID-19 genome sequencing services. As the prime contractor, Aegis Sciences Corporation will perform the sequencing work out of its Nashville, Tennessee laboratory. The one year contract is intended to support the CDC's ongoing efforts to track genetic variations of the SARS-CoV-2 virus through genomic surveillance. No subcontractors or set aside...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a $7,224,693.00 definitive cost contract to the Translational Genomics Research Institute (TGen), a non-profit biomedical research organization. The contract is for "MYCOBACTERIUM TUBERCULOSIS PROTEOME-WIDE EPITOPE DISCOVERY AND HOST TRANSCRIPTOME-WIDE T CELL PHENOTYPING IN HIGH DISEASE BURDEN POPULATIONS" and has an ultimate completion date of September 29, 2025. The contract does not have...
This is a $3,202,949.00 federal contract awarded by the Department of Homeland Security (DHS) Science and Technology Directorate to the Translational Genomics Research Institute (TGen), a non-profit biomedical research organization. The contract is for research and development services to develop and validate a field-ready multiple amplicon sequencing system for detecting and characterizing five biothreat agents: Bacillus anthracis, Francisella tularensis, Yersinia pestis, Burkholderia...
The United States Department of Agriculture Animal and Plant Health Inspection Service (USDA APHIS) awarded a $5.34 million firm fixed price definitive contract to Translational Genomics Research Institute, doing business as TGen Research Institute, to conduct SARS-CoV-2 sample collection and biosecurity assessments in wildlife rehabilitation facilities. The contract will be performed in Phoenix, Arizona over a period of performance from July 1, 2023 through December 31, 2025. No...

This is a $1,074,709 firm fixed-price definitive contract awarded to the Translational Genomics Research Institute (TGen), a non-profit research organization, by the Centers for Disease Control and Prevention (CDC) for the FY 21 BAA TOPIC 8 - TGRI project. The contract has a period of performance through May 14, 2023 and was awarded on May 15, 2021 with no set-aside designation. TGen is a leading institute in precision medicine and translational bioscience, specializing in genomic analyses, sequencing, and biomarker discovery to improve diagnostics and treatments for complex diseases. Through this contract, TGen will likely provide the CDC with a range of genomic research services such as sequencing, data analysis, and biosecurity assessments, building on their past work supporting federal agencies in areas like SARS-CoV-2 surveillance and public health genomics.

Generated 6/21/24, 9:53 AM